Virinchi Ltd (VIRINCHI) — concall transcript | 31 December 2019

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Q3 FY2020 earnings call held on February 5, 2020
🔄 What Changed
Healthcare segment revenue grew to Rs. 41.97 crores (Q3 FY20) with EBIT of Rs. 4.61 crores; IT services revenue declined to Rs. 14.68 crores due to visa regime; debt reduced to Rs. 143 crores
🔮 What's Next
Oncology block to add 100 beds with Rs. 40 crore CAPEX; healthcare occupancy to reach 60% in few years; IT services revenue to stabilize at Rs. 56-58 crores; CAPEX on hold until stabilization
💡 Investor Takeaway
The company is restructuring businesses to unlock value, with healthcare expansion and debt reduction expected to drive future growth and share price appreciation.

Virinchi Limited's Q3 FY2020 earnings call on February 5, 2020 highlighted stable healthcare growth, IT services margin pressure from visa issues, and plans to restructure businesses. Management noted 30% hospital occupancy, Rs. 28,000 average revenue per bed, and Rs. 40 crore CAPEX for oncology expansion. Debt stands at Rs. 143 crores with Rs. 30 crore planned repayment. Promoters intend to buy back shares post April 2020. Key growth drivers include healthcare bed expansion to 600 beds and 5-6% product revenue growth net of one-time license income.

📄 View Original Announcement (PDF)

About Virinchi Ltd (VIRINCHI)

Information Technology · IT - Software · Listed on BSE

Market Cap: ₹159.59 Cr ROE: -6.3% ROCE: -0.1%

View full VIRINCHI stock details →

📡 Get AI alerts when VIRINCHI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIRINCHI — Free

📊 More VIRINCHI filings

See all VIRINCHI filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when VIRINCHI files new disclosures

Track VIRINCHI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIRINCHI — Free

Free account · 2 AI queries/day